Market reports & researches
LOG IN | Services | Contact | Custom Research



Main Healthcare, Pharmaceuticals & Biotechnology Healthcare and drugs U.S. Clinical Chemistry and Immunoassay Reagents Markets
Publications

(Currently 512486 Items)


Partners


Healthcare and drugs / REPORT INFORMATION

U.S. Clinical Chemistry and Immunoassay Reagents Markets

DateFeb, 2004
Pages0
Price / format€3353 / Hard Copy
€2976 / Site License
€4106 / Enterprisewide

€2 951 

Report Information | Custom-Tailored Research | Product Trade Lead


Abstract:
 Smaller Reagent Manufacturers Find New Solutions to Match Larger Manufacturers’ Advantage of Holding Reagent Rental Contracts

Clinical laboratories enthusiasm for solutions that can help reduce huge initial outlays on new instruments is fostering the culture of reagent rental contracts. Through such contracts, an instrument manufacturer rents out analyzers to hospitals or laboratories in exchange for orders for reagents. This method proved to be so popular that it accounted for nearly 75 to 85 percent of all revenue generated within the clinical chemistry and immunoassay reagents market in 2003. However, it also cut out smaller suppliers from the market. These smaller suppliers have been trying to create niche markets by targeting physicians offices and regional reference laboratories. To cater to the lower demand volumes of such sectors, these suppliers have been offering reagents in lower volume packs and using analogs that allow for increased stability of reagents.

This research examines the U.S. Clinical Chemistry and Immunoassay Reagents Markets and discusses the various market trends and opportunities for the reagents. The research segments the market into that for clinical chemistry and immunoassay reagents. It offers revenue forecasts as well as key drivers and restraints affecting market growth.

Advances in Point-of-Care and Combinatorial Testing Spur Market Growth

The quickness of point-of-care (POC) test results has popularized its use among the medical community, boosting demand for new, lower volume analyzers to conduct these tests. The need for more instruments is, in turn, driving sales of additional reagents. Some of these reagents come in the form of higher margin reagent disks or packs, further enhancing revenue. Continued developments such as increasing tests menus while decreasing the size of the analyzers footprints are likely to further increase uptake of POC testing, and consequently, that of reagents.

The clinical chemistry and immunoassay reagents market is also capitalizing on the advances made in diagnostics. Although new tests provide more information on medical conditions, many laboratories and hospitals prefer to use a combination of old and new technologies for obtaining a complete picture. For instance, in cardiology, specific myoglobin and troponin tests are conducted in addition to the regular creatine kinase-MB. These practices augment test volumes and reagent revenues, says the analyst.

Market Growth Expected to Be Mainly Volume Driven

In the total market, clinical chemistry dominates in terms of unit volume with approximately 87.9 percent, while immunoassay reagents lead in revenue with about 67.8 percent share. This is ample evidence of the ‘commodity status’ of most clinical chemistry tests and the growth opportunities for higher margin immunoassay techniques. In future, the markets for both clinical chemistry and immunoassay reagents are expected to be driven by volume demand, especially from an ever-increasing aging population.

The educated patient group is becoming more aware of the availability of various treatment options and is proactively requesting tests, notes the analyst. This is bolstering the unit sales of reagents, especially high-end ones, since patients have been asking for the latest tests for both early diagnosis as well as more comprehensive disease management. Unexpected epidemiological outbreaks such as SARS are also likely to sporadically increase demand for reagents and drive volume and revenue.











Table of contents:
 1. Executive Summary
 1. Executive Summary
  1. Executive Summary
2. Total Market
 1. Market Overview
  1. Introduction
  2. Market Segmentation
  3. Market Snapshot
  4. Definitions
  5. Research Methodology
 2. Market Dynamics
  1. Market Challenges
  a. Reagent Rental Contracts between Laboratories and Large Reagent/Instrument Manufacturers Shut out Smaller Competitors with Less-extensive Product Lines
  b. Push for Integrated Systems Forces Traditional Immunoassay Companies to Move Vertically into Low-margin Clinical Chemistry Space
  c. Increased Development and Placement of Open Reagent Systems Encourages Greater Pricing Competition
  d. Possibility of New Regulations Surrounding the Use and Marketing of ASRs Could Decrease New Test Development
  e. Continued Advancements in Microarray Technology Could Lower Reagent Volumes
  f. Gap in Reimbursement Schedules Delays Return on Investment for New Test Developers
  g. Preferred Vendor Status Requires Reagent Vendors to Offer More Extensive Product Menu
  h. Higher Reagent Costs for Lower Volume Laboratories May Drive away Potential Customers
    2. Strategies
    3. Market Drivers
    a. Increased Use of Point-of-care Testing Expands Market
    b. Reagent Rental Contracts Guarantee Revenues over Long Periods of Time
    c. Aging Population and Increased Life Expectancy Increases Potential Patient Population
    d. Need to Gain More Accurate Picture of Patient Health by Using Combination of New and Old Tests Increases Test Volumes
    e.. Advancements in Proteomics and Genomics Ignite Supplemental Markets
    f. Continued Advancements in Pharmacogenomics Increase the Need for TDM
    g. More Educated Patient Populations Proactively Research and Request Tests, Increasing Revenues
    h. New Testing Methods Increase Revenues from Retests and Reflex Testing
    i. Epidemiological Outbreaks Sporadically Ignite Reagent Demands
    4. Market Restraints
    a. Commodity Status of Some Tests and Panels Restricts Profit Margins
    b. Medical Necessity Requirements Lower the Number of Common Tests and Panels Ordered
    c. Consolidation of Hospital and Reference Laboratories Increases Customer Leverage
    d. Five-year Freeze of Laboratory Fee Schedule Consumer Price Index (CPI) Updates by the Centers for Medicare and Medicaid Services May Force Greater Pricing Competition
    e. Relatively Low Demand for Some Tests Restricts Need for Reagent Purchases to Select Few Laboratories
 3. Unit and Demand Analysis
  1. End User Groups
  2. Unit and Demand Analysis
 4. Pricing and Revenue Analysis
  1. Pricing Analysis
  2. Revenue Forecasts
 5. Competitive Landscape and Trends
  1. Competitive Structure
  2. Market Share Analysis
  3. Market and Technology Trends
3. Clinical Chemistry Reagents Market
 1. Market Overview
  1. Introduction
  2. Select Clinical Chemistry Tests
  3. Market Engineering Measurements
 2. Unit and Demand Analysis
  1. End User Groups
  2. Unit and Demand Analysis
 3. Pricing and Revenue Analysis
  1. Pricing Analysis
  2. Revenue Forecasts
 4. Competitive Environment
  1. Competitive Landscape
  2. Market Share Analysis
4. Immunoassay Reagents Markets
 1. Market Overview
  1. Introduction
  2. Select Immunoassay Tests
  3. Market Engineering Measurements
 2. Unit and Demand Analysis
  1. End User Groups
  2. Unit and Demand Analysis
 3. Pricing Revenue and Competitive Analysis
  1. Pricing Analysis
  2. Revenue Forecasts
 4. Competitive Environment
  1. Competitive Landscape
  2. Market Share Analysis
5. Frost & Sullivan Awards
 1. Frost & Sullivan Awards
  1. Award for Technology Innovation
  2. Award for Product Line Strategy Leadership
  3. Award for Product Differentiation Leadership
  4. Award for Product Innovation
  5. Award for Technology Leadership
6. Decision Support Databases
 1. Decision Support Databases
  1. Hospitals
  2. Physicians
  3. Biological and Medical Scientists
  4. Population 55 and Above
  5. Myocardial Infarction Incidence
  6. Arthritis Prevalence
  7. Diabetes Prevalence
  8. Global Macroeconomic Healthcare Data
   List Of Figures

Chapter 2
.

Clinical Chemistry and Immunoassay Reagents Market: Impact of Top Industry Challenges (U.S.), 2004-2010
Clinical Chemistry and Immunoassay Reagents Market: Challenges and Corresponding Strategies (U.S.), 2004-2010
Clinical Chemistry and Immunoassay Reagents Market: Market Drivers Ranked in Order of Impact (U.S.), 2004-2010
Clinical Chemistry and Immunoassay Reagents Market: Market Restraints Ranked in Order of Impact (U.S.), 2004-2010
Clinical Chemistry and Immunoassay Reagents Market: Unit Forecasts (U.S.), 2000-2010
Clinical Chemistry and Immunoassay Reagents Market: Total Population and 55+ (Years) Population Growth (U.S.), 2000-2010
Clinical Chemistry and Immunoassay Reagents Market: Reagent-only Price Per Test Forecasts (U.S.), 2000-2010
Clinical Chemistry and Immunoassay Reagents Market: Revenue Forecasts (U.S.), 2000-2010
Clinical Chemistry and Immunoassay Reagents Market: Competitive Structure (U.S.), 2003
Clinical Chemistry and Immunoassay Reagents Market: Market Shares of Select Market Participants (U.S.), 2003
Clinical Chemistry and Immunoassay Reagents Market: Market Share by Segment for Unit Volumes and Revenues (U.S.), 2000-2010
Clinical Chemistry and Immunoassay Reagents Market: Database of Key Industry Participants by Reagent Type (U.S.), 2003

Chapter 3
.

Clinical Chemistry Reagents Market: Market Share by Segment for Unit Volumes and Revenues (U.S.), 2000-2010
Clinical Chemistry Reagents Market: Unit Forecasts (U.S.), 2000-2010
Clinical Chemistry Reagents Market: Reagent-only Price per Test Forecasts (U.S.), 2000-2010
Clinical Chemistry Reagents Market: Revenue Forecasts (U.S.), 2000-2010
Clinical Chemistry Reagents Market: Competitive Structure (U.S.), 2003
Clinical Chemistry Reagents Market: Market Shares of Select Market Participants (U.S.), 2003

Chapter 4
.

Immunoassay Reagents Market: Market Share by Segment for Unit Volumes and Revenues (U.S.), 2000-2010
Immunoassay Reagents Market: Unit Forecasts (U.S.), 2000-2010
Immunoassay Reagents Market: Reagent-only Price per Test Forecasts (U.S.), 2000-2010
Immunoassay Reagents Market: Revenue Forecasts (U.S.), 2000-2010
Immunoassay Reagents Market: Competitive Structure (U.S.), 2003
Immunoassay Reagents Market: Market Shares of Select Market Participants (U.S.), 2003




Order this report

  Company name:
  Contact person:
  Phone/fax:
  Email:
  Comments:
   


Product Trade Lead
0 leads found


Add New Buy/Sell Lead

© 2007-2010 MarketReportFinder.com